Volume 10, Issue 3, July 2020

Matrix Release for Asthma (Research Article)

Author(s): Darji Yogesh Kumar Govindbhai and Satyajit Sahoo
Abstract: Nanomedicines have evolved into various forms including dendrimers, nanocrystals, Asthma is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm.[1] Asthma is the result of chronic inflammation of the airways which subsequently results in increased contractability of the surrounding smooth muscles. This among other factors leads to bouts of narrowing of the airway. The narrowing is typically reversible with or without treatment. Occasionally the airways themselves change. Common symptoms include wheezing, coughing, chest tightness.
PAGES: 361-375  |  17 VIEWS  29 DOWNLOADS

How To Cite this Article:

Darji Yogesh Kumar Govindbhai and Satyajit Sahoo. Matrix Release for Asthma (Research Article). 2020; 10(3): 361-375.